Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2026-08-18 09:01:03 ET · period of report 2026-05-18 · accession 0001683168-26-006553 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 09:01 | 2026-05-18 | CNSP | Fisher Michal | Dir | P - Purchase | $5.00 | +2,000 | 2,000 | New | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | P | A | 2,000 | $5.00 | 2,000 | D | — | — |